Medicis Pharmaceutical Corp. (NYSE: MRX) is seeing its shares surging on news that it will be acquired by Valeant Pharmaceuticals International Inc. (NYSE: VRX). What is interesting here is that Valeant is seeing its…
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short interest changes…
Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in recently completed phase 3 double-blind trials.…
Jon OggRosetta Genomics, Ltd. (NASDAQ: ROSG) has had a stellar week so far, and things are looking even better for what had been a battered microRNA-based molecular diagnostic test-maker. Dow Jones reported that a…
The quarterly ExpertRECALL Index released today indicates that more than 123 million medical device units were recalled during the second quarter of 2012, an eight-quarter high. The medical device category includes such products as…
Medtronic Inc. (NYSE: MDT) reported adjusted 2013 first fiscal quarter earnings per share (EPS) of $0.85 on $4 billion in sales before markets opened this morning. In the same period a year ago, the…
In the latest in a string of multi-billion-dollar acquisitions in the U.S. health care sector, Aetna Inc. (NYSE: AET) has agreed to buy competitor Coventry Health Care Inc. (NYSE: CVH) for $5.7 billion in…
You know that if one sector has continued to consolidate through time, it is the biotech sector. We often hear rumors about “the next biotech buyout.” Today’s rumor mill around biotech is around Dendreon…
Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit, but now there is something else to consider. Elan could be getting closer and…
Drug maker Pfizer Inc. (NYSE: PFE) has filed a Form S-1 with the SEC for an initial public offering of the company’s animal health unit into a company to be called Zoetis Inc. Pfizer…
Now that Express Scripts Holding Company (NASDAQ: ESRX) has finally passed and completed its massive merger effort, the company can refocus its efforts and make the changes that it wants to make or needs…
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period that…
Express Scripts Holding Co. (NASDAQ: ESRX) reported second quarter adjusted EPS of $0.88 and $27.7 billion in revenue after markets closed today. EPS for the same period a year ago totaled $0.71, and last…
Drug maker Pfizer Inc. (NYSE: PFE) today announced that it has reached settlements with the US Justice Department and the Securities and Exchange Commission related to improper payments (aka, bribes) paid by six of…
Johnson & Johnson Inc. (NYSE: JNJ) and Pfizer Inc. (NYSE: PFE) both announced they are stopping development of a drug to treat patients with mild to moderate Alzheimer’s after the drug failed a second clinical…